Engelmann; Hartmut

Patent Applications and Registrations

Patent applications and USPTO patent grants for Engelmann; Hartmut.The latest application filed is for "method and kit for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells".

Company Profile

0.11.9

Engelmann; Hartmut - Munich DE
Engelmann; Hartmut - Neubiberg DE
Engelmann, Hartmut - Munchen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Isolated cDNA encoding tumor necrosis factor binding protein II, its purification, and vectors, hosts and processes using such cDNA Grant 8,138,323 - Wallach , et al. March 20, 2	2012-03-20
Method for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells Grant 7,642,046 - Engelmann January 5, 2	2010-01-05
Methods of determining the level of human TBP-II with anti-TBP-II antibody Grant 7,455,977 - Wallach , et al. November 25, 2	2008-11-25
Method and kit for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells App 20060240483 - Engelmann; Hartmut	2006-10-26
DNA encoding tumor necrosis factor inhibitory protein and its use App 20050245731 - Wallach, David ; et al.	2005-11-03
TNF binding ligands and antibodies App 20040161858 - Wallach, David ; et al.	2004-08-19
TNF receptor-specific antibodies App 20030228312 - Wallach, David ; et al.	2003-12-11
DNA molecule encoding TNF binding ligands and vectors and host cells containing the DNA molecule Grant 6,602,993 - Wallach , et al. August 5, 2	2003-08-05
Isolated CDNA encoding tumor necrosis factor binding protein II, its purification, and vectors, hosts and processes using such cDNA App 20030124675 - Wallach, David ; et al.	2003-07-03
Tumor necrosis factor inhibitory protein and its purification App 20020165354 - Wallach, David ; et al.	2002-11-07
Tumor necrosis factor inhibitory protein and its purification App 20020165163 - Wallach, David ; et al.	2002-11-07
TNF binding ligands and antibodies App 20020111462 - Wallach, David ; et al.	2002-08-15
TNF receptor-specific antibodies App 20010019833 - Wallach, David ; et al.	2001-09-06
TNF receptor-specific antibodies Grant 6,262,239 - Wallach , et al. July 17, 2	2001-07-17
TNF ligands Grant 6,232,446 - Wallach , et al. May 15, 2	2001-05-15
Expression of the recombinant tumor necrosis factor binding protein I (TBP-I) Grant 5,811,261 - Wallach , et al. September 22, 1	1998-09-22
DNA that encodes a tumor necrosis factor inhibitory protein and a recombinant method of production Grant 5,695,953 - Wallach , et al. December 9, 1	1997-12-09
Soluble IFN-.beta.2/IL-6 binding protein its preparation, and pharmaceutical compositions containing it Grant 5,621,077 - Novick , et al. April 15, 1	1997-04-15
IFN-.beta.2/IL-6 receptor its preparation and pharmaceutical compositions containing it Grant 5,216,128 - Novick , et al. June 1, 1	1993-06-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.